2
Clinical Trials associated with SFR-9216白蛋白/干扰素α2b多剂量的单次和多次给药在慢性乙型肝炎患者中的耐受性、药代动力学和药效学临床试验
[Translation] Clinical trial on tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of albumin/interferon α2b in patients with chronic hepatitis B
为了考察本品在慢性乙型肝炎患者中单次、多次给药的安全性和耐受性以及药代动力学和药效学指标,并探索其治疗慢性乙型肝炎的初步临床疗效。
[Translation] To investigate the safety and tolerability of single and multiple doses of this product as well as its pharmacokinetic and pharmacodynamic indicators in patients with chronic hepatitis B, and to explore its preliminary clinical efficacy in the treatment of chronic hepatitis B.
注射用重组人血清白蛋白/干扰素α2b融合蛋白在健康成年志愿者中单次给药剂量递增I期临床试验
[Translation] Phase I clinical trial of single-dose escalation of recombinant human serum albumin/interferon α2b fusion protein for injection in healthy adult volunteers
考察本品在健康受试者中的安全性、耐受性以及药代动力学和药效学指标
[Translation] To investigate the safety, tolerability, pharmacokinetic and pharmacodynamic indicators of this product in healthy subjects
100 Clinical Results associated with SFR-9216
100 Translational Medicine associated with SFR-9216
100 Patents (Medical) associated with SFR-9216
100 Deals associated with SFR-9216